| A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age (NCT05084508) | GlaxoSmithKline | 2022-02-03 |
| Safety and Immunogenicity of Skyvaricella Injection in Healthy Volunteer Vietnamese Children From 12 Months to 12 Years Old (NCT04384016) | Vietnam Military Medical University | 2021-04-17 |
| A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age. (NCT02570126) | GlaxoSmithKline | 2015-11-13 |
| Review of Human Herpes Viruses in Burns (NCT02452229) | The University of Texas Medical Branch, Galveston | 2015-03-01 |
| Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine (NCT01815073) | Changchun Keygen Biological Products Co., Ltd. | 2013-03-01 |
| Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella Vaccine (NCT01817270) | Changchun Keygen Biological Products Co., Ltd. | 2013-03-01 |
| Safety and Immunogenicity Study of Live Attenuated Vaccine Against Varicella Without Gelatin (NCT01684072) | Beijing Center for Disease Control and Prevention | 2011-01-01 |
| Varicella-related Hospitalizations in Turkey (NCT01887496) | Eskisehir Osmangazi University | 2010-09-01 |
| Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED) (NCT00326183) | Merck Sharp & Dohme LLC | 2007-03-26 |
| Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection (NCT00098046) | Novartis | 2005-07-01 |
| MMR and Varicella Vaccine in Premature Infants (NCT00156559) | University of Rochester | 2004-01-01 |
| A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune Systems (NCT00002315) | Glaxo Wellcome | |
| A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV (NCT00002358) | Bristol-Myers Squibb | |
| The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children (NCT00001054) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox (NCT00001125) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Comparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected Patients (NCT00000953) | National Institute of Allergy and Infectious Diseases (NIAID) | |